Selank
Regulatory status
Not an approved drug substance in the United States and not on the 503A bulks list. Available to verified facilities for research and manufacturing use only.
Summary
Selank is a seven-residue tuftsin analogue carrying a proline-glycine-proline extension. Like Semax it originates largely from eastern European manufacturers and is frequently quoted alongside it as a pair.
The tuftsin portion is prone to deamidation on storage, so retest date and storage conditions matter as much as the release purity figure when comparing lots of different age.
Typical related substances
Typical related substances are deamidated asparagine variants, truncated tuftsin fragments and residual acetate and water.
Regulatory note
Not an approved drug substance in the United States and not on the 503A bulks list.
Regulatory status shown is our current understanding and is not legal advice. Each facility is responsible for confirming eligibility for its own licence type before purchase.